Defining the role of CD56/NCAM in human natural killer cell polarization and migration

被引:0
|
作者
Martinez, A. L. [1 ]
Shannon, M. J. [1 ]
Mace, E. M. [1 ]
机构
[1] Columbia Univ, Irving Med Ctr, New York, NY USA
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
B520/P2901
引用
收藏
页码:1155 / 1155
页数:1
相关论文
共 50 条
  • [21] CD56 (NCAM)-POSITIVE MALIGNANT-LYMPHOMA
    WONG, KF
    CHAN, JKC
    NG, CS
    LEUKEMIA & LYMPHOMA, 1994, 14 (1-2) : 29 - 36
  • [22] Clinicopathological correlates of plasma cell CD56 (NCAM) expression in multiple myeloma
    Kraj, Maria
    Sokolowska, Urszula
    Kopec-Szlezak, Joanna
    Poglod, Ryszard
    Kruk, Barbara
    Wozniak, Jolanta
    Szpila, Tomasz
    LEUKEMIA & LYMPHOMA, 2008, 49 (02) : 298 - 305
  • [23] CD56 identifies monocytes and not natural killer cells in rhesus macaques
    Carter, DL
    Shieh, TM
    Blosser, RL
    Chadwick, KR
    Margolick, JB
    Hildreth, JEK
    Clements, JE
    Zink, MC
    CYTOMETRY, 1999, 37 (01): : 41 - 50
  • [24] RAPID METHOD FOR PURIFICATION OF CD56(+) NATURAL-KILLER-CELLS WITH PREFERENTIAL ENRICHMENT OF THE CD56(BRIGHT+) SUBSET
    HANDGRETINGER, R
    WELTE, B
    DOPFER, R
    NIETHAMMER, D
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1994, 8 (06) : 443 - 446
  • [25] CASE REPORT: A CD56 NEGATIVE NASAL TYPE NATURAL KILLER T CELL LYMPHOMA
    Wang, Lanqi
    Shen, Xiaoyan
    Zhao, Xiaoqing
    Shi, Ruofei
    Zheng, Jie
    JOURNAL OF DERMATOLOGY, 2014, 41 : 38 - 38
  • [26] Primary cutaneous extranodal natural killer/T cell lymphoma with delayed expression of CD56
    Kobayashi, Aiko
    Goto, Hiroyuki
    Negishi-Asano, Airi
    Sowa-Osako, Junko
    Tanaka, Sayaka
    Ohe, Chisato
    Kohashi, Kenichi
    Tsuruta, Daisuke
    Tateishi, Chiharu
    EUROPEAN JOURNAL OF DERMATOLOGY, 2023, 33 (06) : 705 - 706
  • [27] CD7 and CD56 positive myeloid/natural killer cell precursor acute leukemia.
    Suzuki, R
    Seto, M
    Taji, H
    Yatabe, Y
    Kagami, Y
    Ogura, M
    Ueda, R
    Morishima, Y
    Nakamura, S
    BLOOD, 1997, 90 (10) : 2219 - 2219
  • [28] NCAM(CD56) AND CD31 IN PATIENTS WITH PRIMARY HYPERTENSION
    Soya, O. V.
    Kuryata, O. V.
    Nedzvedskiy, V. S.
    JOURNAL OF HYPERTENSION, 2009, 27 : S149 - S150
  • [29] Reduction in CD16/CD56 and CD16/CD3/CD56 Natural Killer Cells in Coronary Artery Disease
    Jabir, Nasimudeen R.
    Firoz, Chelapram K.
    Ahmed, Farid
    Kamal, Mohammad A.
    Hindawi, Salwa
    Damanhouri, Ghazi A.
    Almehdar, Hussein A.
    Tabrez, Shams
    IMMUNOLOGICAL INVESTIGATIONS, 2017, 46 (05) : 526 - 535
  • [30] Role of interleukin-15 in the development of human CD56(+) natural killer cells from CD34(+) hematopoietic progenitor cells
    Mrozek, E
    Anderson, P
    Caligiuri, MA
    BLOOD, 1996, 87 (07) : 2632 - 2640